5th March 2010

Plenary: National Programs for Innovation and Enterprise Growth
1. Mr Jon Sandelin, Senior Associate Emeritus, Stanford University Office of Technology Licensing, USA (Moderator)
2. Mr Lawrence Koe, Director (Projects), National Research Foundation (NRF), Singapore
3. Prof. Dr. Rofina Yasmin Binti Othman, Ministry of Science Technology and Innovation (MOSTI), Malaysia
4. Dr Edward Rubesch, Director, Technology Licensing Office, National Science and Technology Development Agency (NSTDA), Thailand

Plenary: Commercialization and Investment Opportunities in Emerging Technology Fields
1. Mr Edmund Yong, Managing Partner, Accel-X Pte Ltd (Moderator)
2. Dr Frank Levinson, Founder and Managing Director, Small World Group
3. Mr Brad Greenspan, Founder, MySpace
4. Mr Barry Drayson, Managing Director, Innoveas AG

5. Mr Guy Proulx, Managing Director, Transpacific IP Management Group Pte Ltd

6th March 2010

Technology Tracks

Track 1 - Cleantech:
(A) Launch of NUS Membrane Consortium
(B) Panel: Applications and Uses of Membrane Technology in Cleantech Industry Panel Members:
1. Dr. Michael Quah, Principal Fellow, Energy Studies Institute (Moderator)
2. Frank Levinson, Founder and Managing Director, Small World Group
3. Prof Neal Chung, Faculty of Engineering, NUS
4. Dr Rinse Terpstra, MD & Chief Technology Officer, Hyflux

Track 2 - ICT/IDM:
Panel discussion: Using and Commercializing Open Source Software
Panel Members:
1. Prof Martin Henz, School of Computing, National University of Singapore (Moderator)
2. Stephen Gillespie, Partner, Fenwick & West LLP
3. Gerald Barnett, Research Technology Enterprise Initiative, University of Washington

Track 3 - Biomedical Sciences:
Panel Discussion: Bringing Early Stage Technology to Market
Panel members:
1. Dr. Lim Jui, Executive Director, MERCI (Medical Engineering Research and Commercialization Initiative), National University of Singapore (Moderator)
2. Mr Arundeep S. Pradhan, President, AUTM
3. Dr Andrew Serafini, Partner, Fenwick & West LLP
4. Dr Paul MacAry, Assistant Professor, Department of Microbiology, NUS

Open innovation. Presentations by companies in the areas of:

Biomedical Sciences Track:

Johnson Chen, Managing Partner, Clearbridge Accelerator

Wanting to see your inventions being adopted in the market place? Need help, mentoring and financing? Want to find out more about commercialisation? This is a brief overview of what investors tend to look for, the challenges and the various business paths and sources of finance.

ICT/IDM Track:

Patrick Ennis, Global Head of Technology, Intellectual Ventures

It is an exciting time to be a technologist. Every day, breakthroughs in research laboratories offer the promise of products and solutions to meet a range of global challenges and opportunities.  However, it is very difficult to successfully commercialize technology; and unfortunately most efforts fail.  We need to improve the success rate, otherwise billions of dollars of R&D funding will be wasted, and innovation-driven economies will stall. Invention Capital is a missing link in the value-creation chain.

Cleantech Track:

Professor Peter Heydebreck, Managing Director, innoveas AG
innoveas AG is the leading German enterprise in the field of IP incubation. The process is as traditional as it is complete: innoveas enters deals via its subsidiary company, Engage Key Technology Ventures, which analyses and selects IP for IP protection and development, builds teams to exploit the technology and works closely with leading public research institutions whose scientists are at the heart of innovation. innoveas manages deals through its M.O.R.E. (Money out of Research Excellence) INVEST GmbH & Co KG. M.O.R.E. is an investment fund which specialises in financing the growth of innoveas’ ventures and preparing them for exit via IPO, corporate acquisition or joint venture.